Food Effect Study of Alisertib (MLN8237) in Participants With Advanced Solid Tumors or Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Advanced Solid Tumors
Related studies linked through entity extraction aliases.
Study Comparing the Pharmacokinetics of FTD as a Component of TAS-102 With FTD Alone
- Status
- COMPLETED
- Phase
- PHASE1
A Clinical Pharmacodynamic and Pharmacogenetic Study of OPB-51602 in Patients With Advanced Solid Tumours
- Status
- UNKNOWN
- Phase
- N/A
A Phase Ia, Dose Escalation Study of Humanized Anti-VEGF Monoclonal Antibody (Sevacizumab) Injection in Patients With Advanced or Metastatic Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
Pharmacokinetics Study of Oral Ixazomib (MLN9708) in Relapsed/Refractory Multiple Myeloma and Advanced Solid Tumors Participants With Normal Renal Function or Severe Renal Impairment
- Status
- COMPLETED
- Phase
- PHASE1
Phase I Dose-Escalation, Safety, Pharmacokinetic and Pharmacodynamic Study of BVD-523 in Patients With Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
An Open-label, Dose Escalation, Pharmacodynamic, Pharmacokinetic, and Effect of Food Phase 1 Study of E7820 to Determine the Maximum Tolerated Dose Following Twice Daily Oral Administration in Subjects With Unresectable Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 1 Study Evaluating AMG 232 in Advanced Solid Tumors or Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Mass Balance, Pharmacokinetics and Metabolism Study of Alisertib
- Status
- COMPLETED
- Phase
- PHASE1
Study to Investigate the Pharmacolkinetics of Aldoxorubicin (INNO-206;DOXO-EMCH) Administered as a 30 Minute Infusion Every 3 Weeks in Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 1/2 Study to Evaluate MEDI4736
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Multicentre, Open Label, Phase 1 Trial in Japan of the Mitogen Activated Protein Extracellular Signal Regulated Kinase (MEK) Inhibitor Pimasertib Given Orally to Subjects With Solid Tumors as Monotherapy
- Status
- TERMINATED
- Phase
- PHASE1
Determination of Intratumoral Concentrations of Kinase Inhibitors in Patients With Advanced Solid Malignancies.
- Status
- COMPLETED
- Phase
- NA
Phase 1/2 Study of X-396, an Oral ALK Inhibitor, in Patients With ALK-positive Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of TAS-114 in Combination With S-1 in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
BKM120 + mFOLFOX6 in Advanced Solid Tumors With Expansion Cohort Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Look at How a Single Oral Dose of 14C-OSI-906 is Absorbed, Broken Down and Eliminated in the Body
- Status
- COMPLETED
- Phase
- PHASE1
First in Human Trial of TAS266 in Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
A Dose Escalation Study of Hydroxyurea in Combination With SCH900776 in Advanced Malignant Solid Tumors
- Status
- WITHDRAWN
- Phase
- PHASE1